CAITLIN BUNKER: Open Payments
NPI 1356039275 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 7 payments from 6 companies in 2025. Trend: 2023 $469 · 2024 $959 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $188 |
| Pharmacosmos Therapeutics Inc. | 1 | $136 |
| Janssen Biotech, Inc. | 1 | $134 |
| PFIZER INC. | 1 | $103 |
| GENZYME CORPORATION | 1 | $85 |
| Incyte Corporation | 1 | $28 |
Products named: COSELA, RYBREVANT, HYMPAVZI, REBLOZYL, BREYANZI, JAKAFI.
Industry payments across OH — which companies pay providers there.
